New drug combo aims to boost lymphoma treatment
Disease control
Not yet recruiting
This trial tests whether adding an experimental drug called birelentinib to standard chemotherapy (R-CHOP) improves outcomes for people with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Participants receive either birelentinib plus R-CHOP or a placebo plus R-CHOP. The s…
Phase: PHASE2, PHASE3 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC